ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MAV4 Maven Income & Growth Vct 4 Plc

57.50
0.50 (0.88%)
03 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Maven Income & Growth Vct 4 Plc LSE:MAV4 London Ordinary Share GB00B043QW84 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 0.88% 57.50 56.50 58.50 57.50 57.00 57.00 5,555 12:17:51
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Mgmt Invt Offices, Open-end -1.43M -4.31M -0.0306 -18.79 80.17M

Maven Income & Growth VCT 4 PLC Half-year Report

18/09/2024 11:09am

RNS Regulatory News


RNS Number : 7038E
Maven Income & Growth VCT 4 PLC
18 September 2024
 

Maven Income and Growth VCT 4 PLC

 

Interim Results for the Six Months Ended 30 June 2024

 

Highlights

 

•    NAV total return at 30 June 2024 of 155.04p per share

 

•    NAV at 30 June 2024 of 62.19p per share

 

•    Interim dividend of 2.00p per share

 

•    Offer for Subscription closed, raising £5.8 million

 

•    Two new private companies added to the portfolio, with a further two investments completed post period end

 

•    Exit achieved from GradTouch, generating a total return of 1.5x cost

 

•    Final exit achieved from Quorum Cyber, generating a total return of 8.2x cost

 

•    Post period end partial exit achieved from MirrorWeb, generating a total return of 4.7x cost, including an ongoing equity stake

 

•    Post period end partial exit achieved from Novatus Global, generating a total return of 4.7x cost, including an ongoing equity stake

 

•    Post period end exit achieved from CB Technology, generating a total return of 2.9x cost

 

Interim Review

 

Overview

 

In the six months to 30 June 2024, your Company has made further positive progress and it is pleasing to report an increase in NAV total return. Since the year end, there has been a strong level of M&A activity across the private company portfolio, which has resulted in the completion of five profitable realisations, including several high value exits to strategic US buyers. In June, the sale of the residual interest in Quorum Cyber completed, generating a total return of 8.2x cost over the life of the investment and, in August, the partial sale of MirrorWeb completed, generating a total return of 4.7x cost, with the partial exit from Novatus Global completing in early September and generating a total return of 4.7x cost. With MirrorWeb and Novatus, the exit considerations consisted of a combination of cash and a continuing equity stake, which allows your Company to participate in the future growth of these businesses with scope for a further return in the future. In recognition of the exit activity and the commitment to make regular tax free distributions, an increased interim dividend of 2.00p per share has been declared for payment in October 2024.

 

In the year to date, your Company has completed five profitable private company exits to UK and US buyers, helping to validate the Manager's investment strategy and sector focus. Following a muted period for M&A within the technology sector in 2023, the market has recovered strongly. Notably, there has been a reemergence of US private equity buyers who are attracted to UK speciality software companies that have a market leading product and a clear path to scalable growth. A key part of their acquisition rationale is to provide financial resource to help these businesses accelerate growth plans and realise their full potential.

 

In early June, the final exit from cyber security specialist Quorum Cyber completed with the sale of the residual holding. Your Company first invested in Quorum in 2020, backing an experienced team that had established a leading position in a high growth market. Following a period of rapid expansion, the investment was partially realised through a sale to UK private equity house Livingbridge in December 2021, generating an initial return of 6.5x cost over an 18 month holding period. This transaction provided Quorum with additional capital to support the next phase of its strategic development and, in recognition of the growth prospects, the Maven VCTs retained a minority equity interest in the business in order to participate in its future success. In June this year, a final exit from this investment was achieved through a sale of the business to US private equity firm, Charlesbank Capital Partners, taking the total proceeds to 8.2x cost over the life of the investment.

 

A further notable exit was the partial sale of digital archiving specialist MirrorWeb, which completed in August 2024. Your Company first invested in MirrorWeb in 2020, supporting an ambitious management team who had developed a disruptive software platform with significant growth potential and a large addressable market. Since investment, the business consistently delivered strong revenue growth and established a leading position in the communications surveillance market, with a focus on the financial services sector where the platform supports regulatory requirements in relation to data archiving. In 2023, the business successfully expanded into the US, which led to an unsolicited approach to acquire the business from a US private equity buyer. Following this approach, a competitive exit process was initiated, with the sale to US private equity acquirer MainSail completing in August. The exit generated a total return of 4.7x cost, comprising of a cash consideration and an ongoing equity stake that enables your Company to maintain an economic interest in the business with the potential for a further return in the future.

 

In early September 2024, the partial sale of regtech specialist Novatus Global completed, achieving the highest value sale price to date from your Company's unlisted technology portfolio. Following investment by your Company, Novatus made rapid commercial progress, capitalising on the growth opportunities within its core market, where its advisory services and software platform helps financial institutions to prevent and resolve regulatory and compliance issues. Over the past two years, the business achieved a 250% increase in annual recurring revenue (ARR), driven by the development of its proprietary transaction reporting software platform, which is gaining market traction and a strong reputation. The business recently opened its first international office in Australia to capture the significant opportunity in this region. Novatus received an unsolicited acquisition approach from US private equity firm Silversmith Capital Partners at a premium to carrying value, reflective of the strategic value of the technology. The exit generated a total return of 4.7x cost, which includes cash and an ongoing equity element that enables your Company to participate in the future growth of this business.

 

Specialist electronics manufacturer CB Technology was one of the more mature holdings in the portfolio and, following a period of strong trading performance, an exit process was initiated in 2023. An offer to acquire the business was subsequently received from a private equity backed trade acquirer, with the exit completing in early September 2024 and generating a total return of 2.9x cost. In addition, in May 2024 your Company completed the exit from graduate recruitment specialist GradTouch, with a sale to a UK private equity house that generated a total return of 1.5x cost, inclusive of a small deferred element.

 

Achieving profitable exits in order to maximise Shareholder returns and distributions remains a key priority. However this has to be balanced against selling a business too early before its value has been fully optimised. In cases like Quorum, MirrorWeb and Novatus, where a business is performing strongly and has the potential to become a large and valuable asset, the Manager will seek to maintain an economic interest when structuring an exit. This approach allows your Company to generate a healthy initial cash return from a secondary transaction or partial sale, to help support the dividend programme, whilst retaining an ongoing equity interest in the business, which offers the potential for a further return in the future.

 

Your Company continues to make further progress in line with its long term growth strategy, which is focused on constructing a large and diverse portfolio of innovative companies that have the potential to grow rapidly and ultimately become attractive to a wide range of acquirers. During the reporting period, a total of £2.6 million was deployed through the addition of two new private companies to the portfolio, alongside the provision of follow-on funding to support the further development of 13 existing unlisted holdings, as well as two small AIM transactions. The investment strategy continues to focus on identifying entrepreneurial companies that operate in disruptive or high growth markets, where there is an opportunity to achieve scale over the medium term. Maven retains a strong preference for investing in companies that operate in dynamic sectors such as cyber security, software, niche manufacturing, data analytics, healthtech and training, where growth is less sensitive to consumer or discretionary spending and the revenue model tends to be recurring in nature, which provides good visibility on the growth trajectory of each portfolio company. To ensure that the business plan can be delivered, Maven also spends time assessing the calibre of management and their track record, recognising that experienced and cohesive teams are crucial to the success of early stage businesses.

 

In April 2024, your Company closed its most recent top-up Offer having raised a total of £5.8 million for the 2023/24 and 2024/25 tax years. These funds will enable your Company to progress its investment strategy which, over the past four years, has provided growth capital to more than 40 private companies, many of which are delivering strong growth and achieving a leading position in their respective markets.

 

Dividend Policy

 

The Board and the Manager recognise the importance of tax free distributions to Shareholders and will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the immediately preceding year end. This policy is under close and regular review by the Board and the Manager, particularly in light of the current level of profitable exit activity.

 

Decisions on distributions take into consideration a number of factors, including the realisation of capital gains, the adequacy of distributable reserves, the availability of surplus revenue and the VCT qualifying level, all of which are kept under close and regular review. As the portfolio continues to expand and a greater proportion of holdings are invested in younger companies with growth potential, the timing of distributions will be more closely linked to realisation activity, whilst also reflecting the Company's requirement to maintain its VCT qualifying level.

 

Interim Dividend

 

In respect of the year ending 31 December 2024, an increased interim dividend of 2.00p per share will be paid on 18 October 2024 to Shareholders who are on the register at 20 September 2024. Since the Company's launch, and after receipt of this interim dividend, a total of 94.85p per share will have been paid in tax free Shareholder distributions. It should be noted that the payment of a dividend reduces the NAV of the Company by the total amount of the distribution.

 

Dividend Investment Scheme (DIS)

 

Your Company operates a DIS, through which Shareholders can, at any time, elect to have their dividend payments utilised to subscribe for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax relief applicable for the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances.

 

Shareholders can elect to participate in the DIS in respect of future dividends by completing a DIS mandate form and returning it to the Registrar (The City Partnership). In order for the DIS to apply to the 2024 interim dividend, the mandate form must be received before 4 October 2024, this being the relevant dividend election date. The mandate form, terms & conditions and full details of the scheme (including tax considerations) are available from the Company's webpages at: mavencp.com/migvct4. Election to participate in the DIS can also be made through the Registrar's online investor hub at: maven-cp.cityhub.uk.com/login.

 

If a Shareholder is in any doubt about the merits of participating in the DIS, or their own tax status, they should seek advice from a suitably qualified adviser.

 

Offer for Subscription

 

The most recent Offer for Subscription closed on 26 April 2024, with your Company raising a total of £5.8 million for the 2023/24 and 2024/25 tax years. All new shares in relation to this Offer have now been issued, with four allotments for the 2023/24 tax year and one allotment for the 2024/25 tax year.

 

This additional liquidity will facilitate the further expansion and development of the portfolio in line with the investment strategy. The funds raised will also allow your Company to maintain its share buy-back policy, whilst also spreading costs over a wider asset base, with the objective of maintaining a competitive ongoing charges ratio for the benefit of all Shareholders.

 

As announced on 18 June 2024, the Directors have elected to launch a new Offer for Subscription, which will run alongside Offers by the other Maven managed VCTs. Full details will be included in the Prospectus, which is expected to be published in Autumn 2024.

 

Portfolio Developments

 

It is encouraging to report on the progress that has been achieved across the private equity portfolio, where most companies have continued to meet operational and financial targets as part of their business plans. Many of the earlier stage growth companies are now achieving scale and establishing strong positions in their respective markets and, in recognition of the progress achieved, the valuations of certain holdings have been uplifted.

 

Cyber security specialist CYSIAM continues to make positive progress, with revenues increasing by more than 200% since your Company first invested. The business is building a strong reputation as a leading provider of Managed Detection and Response (MDR) security services for protection against, detection of and response to cyber attacks. CYSIAM is a recognised expert in its field and, as an accredited member of the National Cyber Security Centre's Cyber Incident Response scheme, it can provide direct support to a range of organisations when they become victims of cyber attacks. CYSIAM operates in a dynamic, high growth market and the near term strategic objective remains to further pivot the business towards a Software as a Service (SaaS) model, which will result in an increased level of recurring revenue.

 

In 2021, your Company invested in Guru Systems, a supplier of hardware, software and data analytics designed to improve the performance and cost effectiveness of heat networks. Since investment, the business has gained commercial traction in an emerging sector that has positive ESG credentials. Heat networks are an important part of the government's decarbonisation strategy and are increasingly required to be included as part of the design of any new residential and commercial property developments. Given the strong growth potential of this market, Guru is well placed to achieve scale over the medium term.

 

Carbon reduction software specialist Manufacture 2030 has delivered impressive revenue growth over the past year, with ARR increasing by over 75%. The business provides a disruptive software solution that helps multinationals achieve Scope 3 carbon reduction targets by measuring, managing and reducing carbon emissions across their supply chain. The business is establishing a leading position in a high growth market, where its proposition is aligned with various carbon reduction initiatives including the United Nations Sustainable Development Goals. Manufacture 2030 partners with a wide range of blue chip clients, including Asda, Co-op, GSK, Toyota and Unilever, and has received a number of awards as a technology pioneer within this evolving sector. The near term objective is to expand its presence in North America, which is viewed as a key growth market.

 

Automotive ecommerce software specialist Rockar continues to increase its market share and is now a leading provider of a disruptive white label solution for buying and selling new and used cars online. The business has signed commercial agreements with various high profile automotive manufacturers such as BMW, Jaguar Land Rover, Toyota Motor Group and Volvo UK, with development work ongoing with several others. Rockar's new operating platform, Evolution, is gaining traction amongst clients, with a number already using or committed to migrating across to the new operating system. The business continues to deliver strong revenue growth and remains focused on building relationships with global automotive manufacturers, and the outlook for the year ahead is encouraging.

 

Digital payments software provider QikServe has made further encouraging commercial progress and is capitalising on the shift within the hospitality sector towards mobile ordering and pay-at-table technology. The business continues to expand its market presence in targeted sectors that include restaurants, international coffee chains and transportation hubs. QikServe has a growing estate, with more than 8,000 sites in over 40 countries and a healthy pipeline of near term opportunities, particularly in the US.

 

Contract software specialist Summize continues to make positive commercial progress, with ARR growing by almost 200% since the Maven VCTs first invested in October 2022. The business has developed an AI-powered digital contracting software solution that simplifies and streamlines the process for writing and renewing contracts, helping to drive operational efficiencies for customers. Since inception in 2018, Summize has secured numerous industry awards for its innovation and entrepreneurialism. Having established a strong foothold in the UK, the next phase of growth for the business is to expand into the US, where a significant market opportunity has been identified.

 

As may be expected with a large portfolio, there are a small number of investee companies that have not achieved commercial targets and are trading behind plan. Protective provisions have, therefore, been taken against the cost of certain holdings. The performance of fintech specialist Delio has been impacted by slower than expected sales cycles and, although corrective measures have been taken, the business continues to trade behind plan. As a result of significant underperformance, the Manager elected not to provide further support to Drovo and Turnkey, and the valuations of these holdings have been written down in full.

 

Treasury Management

 

Your Company maintains a proactive approach to treasury management, where the objective remains to optimise the income generated from cash held prior to investment in VCT qualifying companies, whilst meeting the requirements of the Nature of Income condition. This is a mandatory part of the VCT legislation, which stipulates that not less than 70% of a VCT's income must be derived from shares or securities. During 2023, the rise in interest rates required the Board and the Manager to revise its approach and, following a whole of market review, the composition of the treasury management portfolio was expanded to include holdings in leading money market funds and open ended investment companies (OEICs), alongside carefully selected London Stock Exchange listed investment trusts. This approach enables your Company to maintain compliance with the Nature of Income condition, whilst also generating a healthy new stream of income from the portfolio of treasury management holdings and cash.

 

In line with the liquidity requirements of your Company, there were several new investments and realisations within the Treasury Management portfolio, details of which can be found in the Interim Report.

 

New Investments

 

During the reporting period, two new private companies were added to the portfolio:

 

•     Alderley Lighthouse Labs is a provider of clinical diagnostic testing services, specialising in the analysis of human samples such as blood, urine and cells, with the objective of improving healthcare outcomes. The business was initially established as a COVID-19 testing facility, as part of the Government supported "Test and Trace" programme. As pandemic related testing subsided, the business evolved into a laboratory based facility providing blood science and molecular diagnostics to a wide range of clients. The healthcare testing market continues to experience high growth and Alderley is well placed to leverage its existing position, with scope to achieve considerable scale. The funding from the Maven VCTs provides capital that will enable the business to invest in product development, expand its current suite of services and grow monthly revenues.

 

•     Zing is a specialist services provider operating in the cloud-communications sector. It is a leading partner of global cloud communication platform business Twilio, providing consultancy and managed services. Zing was spun out from CRM provider ProspectSoft, a previous Maven portfolio company, which was successfully exited in 2022. The funding from the Maven VCTs will enable the business to benefit from the growth opportunities in the Communications Platform as a Service (CPaaS) market. Since becoming an independent business, Zing has made encouraging commercial progress and strengthened its relationship with Twilio. The next stage of development is focused on expanding into the US, developing a new AI proposition, and enhancing the management team through new strategic hires.

 

The following investments were completed during the reporting period:

 

 

Investments

Date

Sector

£'000

 

New unlisted

 

 

 

 

Alderley Lighthouse Labs Limited1

April & May 2024

Pharmaceuticals,

biotechnology & healthcare

249

 

Zing TopCo Limited

(trading as Zing)1

April & May 2024

Business services

185

 

Total new unlisted

 

 

434

 

 

Follow-on unlisted

 

 

 

 

Bud Systems Limited

May 2024

Learning & development/ recruitment technology

116

 

Delio Limited

February 2024

Software & technology

125

 

Draper & Dash Limited

(trading as RwHealth)1

April & May 2024

Pharmaceuticals,

biotechnology & healthcare

68

 

Hublsoft Group Limited

April 2024

Software & technology

56

 

Liftango Group Limited

March 2024

Software & technology

269

 

mypura.com Group Limited

(trading as Pura)

March 2024

Business services

193

 

Relative Insight Limited

February 2024

Software & technology

66

 

Shortbite Limited (trading as Fixtuur)

April 2024

Software & technology

37

 

Snappy Shopper Limited

April 2024

Software & technology

11

 

Summize Limited

June 2024

Software & technology

348

 

Turnkey Group (UK) Holdings Limited2

January, February,

April & June 2024

Software & technology

335

XR Games Limited

February 2024

Software & technology

48

 

Zinc Digital Business Solutions Limited1

March & May 2024

Software & technology

239

 

Total follow-on unlisted

 

 

1,911

 

 

 

 

 

 

Total unlisted

 

 

2,345

 

 

New AIM quoted

 

 

 

 

Cambridge Cognition Holdings PLC

June 2024

Pharmaceuticals,

biotechnology & healthcare

62

 

Total new AIM quoted

 

 

62

 

 

Follow-on AIM quoted

 

 

 

 

GENinCode PLC

January 2024

Pharmaceuticals,

biotechnology & healthcare

160

 

Total follow-on AIM quoted

 

 

160

 

 

 

 

 

 

Total AIM quoted

 

 

222

 

 

Open ended investment companies3

 

 

 

 

Royal Lond Short Term Money Market Fund (Class Y Income)

April 2024

Money market fund

1,000

 

Total open-ended investment companies

 

 

1,000

 

 

Money market funds3

 

 

 

 

Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3)

May 2024

Money market fund

1,000

 

BlackRock Institutional Sterling Liquidity Fund (Core)

March 2024

Money market fund

1,000

 

Fidelity Institutional Liquidity Sterling Fund (Class F)

March 2024

Money market fund

1,000

 

Goldman Sachs Sterling Liquid Reserves (Institutional)

January 2024

Money market fund

1,000

 

Total money market funds

 

 

4,000

 

 

 

 

 

 

Total investments

 

 

7,567

 

 

1 Follow-on investment completed in two tranches.

2 Follow-on investment completed in four tranches.

3 Investments completed as part of the treasury management strategy.

 

At the period end, the portfolio comprised of 131 unlisted and quoted investments, at a total cost of £73.4 million.

 

Realisations

 

In May 2024, the exit from graduate recruitment specialist GradTouch completed. Your Company first invested in GradTouch in November 2019, backing a team with a strategic plan to build a market leading position in the graduate recruitment market. Throughout the period of ownership, the company achieved steady organic growth alongside a series of self funded, complementary acquisitions that helped to transform the business. During the period under review, an offer to acquire the business was received from UK private equity house Pelican Capital, and the exit generated a total return of 1.5x cost, inclusive of a small deferred consideration.

 

The table below gives details of the realisations completed during the reporting period, including the exit from Quorum Cyber, which completed in June 2024:

 

Realisations

 

Year first

invested

 

Complete/

partial exit

Cost of shares

disposed

of

£'000

 

Value at 31

December

2023

£'000

Sales proceeds

£'000

 

Realised

gain/(loss)

£'000

Gain/(loss) over 31 December 2023 value

£'000

Unlisted

 

 

 

 

 

 

 

GradTouch Limited

2019

Complete

200

292

303

103

11

Project Falcon Topco Limited (trading as Quorum Cyber)

2021

Complete

419

419

1,278

859

859

Other unlisted

 

 

3

-

14

11

14

Total unlisted

 

 

622

711

1,595

973

 

AIM quoted

 

 

 

 

 

 

 

Faron Pharmaceuticals Oy

2019

Complete

71

83

48

(23)

(35)

Oncimmune Holdings PLC

2021

Complete

100

14

13

(87)

(1)

RUA Life Sciences PLC

2020

Complete

133

37

42

(91)

5

Verici Dx PLC

2020

Partial

65

31

26

(39)

(5)

Total AIM quoted

 

 

369

165

129

(240)

 

Money market funds1

 

 

 

 

 

 

 

Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3)

2023

Partial

1,000

1,000

1,000

-

-

Goldman Sachs Sterling Liquid Reserves (Institutional)

2024

Complete

1,000

-

1,000

-

-

HSBC Sterling Liquidity Fund (Class A)

2023

Complete

1,000

1,000

1,000

-

-

Total money market funds

 

 

3,000

2,000

3,000

-

-

 

Open-ended investment companies1

 

 

 

 

 

 

 

Royal London Short Term Money Market Fund (Class Y Income)

2023

Partial

986

983

974

(12)

(9)

Total open-ended investment companies

 

 

986

983

974

(12)

(9)

 

 

 

 

 

 

 

 

Total realisations

 

 

4,977

3,859

5,698

721

 

1 Realisations completed as part of the treasury management strategy.

 

During the year, one private company was struck off the Register of Companies, resulting in a total realised loss of £249,000 (cost £249,000). This had no effect on the NAV of the Company as a full provision had been taken against the value of the holding in a previous period.

 

Material Developments Since the Period End

 

Since 30 June 2024, two new private company holdings have been added to the portfolio:

 

·        Automated Analytics is the developer of a sales and marketing platform that tracks the conversion of online "clicks" once they become offline conversions, thereby enabling marketing and recruitment professionals to optimise campaigns and budgets effectively. The platform uses advanced data analytics alongside proprietary AI technology to analyse and process large sets of data in real time, in order to allow clients to maximise the impact of marketing spend and measure the true success of a digital campaign. Since 2021, the business has achieved a fivefold increase in ARR and built a strong customer base that includes household names such as British Gas, Europcar, KFC and Pizza Hut. The funding from the Maven VCTs is being used to accelerate growth by expanding into new markets and making a number of strategic hires to help further develop the technology platform. 

 

·        Connected Data is a provider of a data enabled debt management software solution, that is designed to improve recovery outcomes for utility and financial services companies, which arise during unnotified changes in tenancy and result in billions of pounds of unpaid energy and other bills. The cloud-based platform uses propriety technology to help manage the debt life cycle from pre-delinquency through to late stage collection, offering a more cost effective solution to using a single credit bureau, whilst also using multiple data sets to ensure fairer outcomes for customers. The business is gaining commercial traction and has quickly established a blue chip client base. The funding from the Maven VCTs will be used to further develop the technology platform and invest in sales and marketing.

 

Principal and Emerging Risks and Uncertainties

 

The principal and emerging risks and uncertainties facing the Company were set out in full in the Strategic Report contained within the 2023 Annual Report, and are the risks associated with investment in small and medium sized unlisted and AIM quoted companies which, by their nature, carry a higher level of risk and are subject to lower liquidity than investments in larger quoted companies. The valuation of investee companies may be affected by economic conditions, the credit environment and other risks, including legislation, regulation, adherence to VCT qualifying rules and the effectiveness of the internal controls operated by the Company and the Manager. These risks and procedures are reviewed regularly by the Risk Committee and reported to your Board. The Board continues to monitor the criteria for VCT qualifying status and can confirm that these are being adhered to.

 

Global conflict and political instability was added to the Risk Register as an emerging risk during a previous period, as the Directors were not only aware of the heightened cyber security risk but were mindful of the impact that any change in the underlying economic conditions could have on the valuation of investment companies. These included fluctuating interest rates, increased fuel and energy costs, and the availability of bank finance, all of which could be impacted during times of geopolitical uncertainty and volatile markets. The Board and the Manager continue to monitor the impact of geopolitical issues, and wider market conditions, on portfolio companies.

 

Share Buy-backs

 

In order to maintain an orderly market in the Company's shares, the Directors have delegated authority to the Manager to enable the Company to buy back shares in the secondary market for cancellation or to be held in treasury, subject always to such transactions being in the best interests of Shareholders.

 

It is intended that the Company will seek to buy back shares with a view to maintaining a share price that is at a discount of approximately 5% to the latest published NAV per share, subject to market conditions, availability liquidity and the maintenance of the Company's VCT qualifying status. During the period under review, 2,214,662 shares were bought back at a total cost of £1.28 million.

 

Shareholders should note that neither the Company nor the Manager can execute a transaction in the Company's shares and an instruction to buy or sell shares on the secondary market must be directed through a stockbroker. If a Shareholder wishes to discuss a transaction, they or their broker can contact the Company's stockbroker, Shore Capital Stockbrokers on 020 7647 8132. Such transactions are, however, prohibited whilst the Company is in a closed period, which is the time from the end of a reporting period until the announcement of the relevant results, or the release of an unaudited NAV. Additionally, a closed period may be introduced if the Directors and Manager are in possession of price sensitive information.

 

VCT Regulatory Update

 

During the period under review, there were no further amendments to the rules governing VCTs, and your Company remains fully compliant with the complex conditions and requirements as set out by HMRC.

 

Although the precise details of the new Government's economic and fiscal policy are currently unknown, the Manager has, through the VCT Association (VCTA), been actively involved in positive cross party dialogue to promote and reinforce the important role that VCTs play in supporting some of Britain's brightest and most entrepreneurial smaller companies, whilst also assisting in job creation across the regions. It is pleasing to note that, on 3 September 2024, HM Treasury approved the regulations required to lift the "sunset clause" and extend VCT and EIS schemes until 2035. This provides greater certainty to SME's seeking growth capital that VCTs will remain a central component of the UK's funding infrastructure.

 

Valuation Methodology

 

Consistent with industry best practice, the Board and the Manager continue to apply the International Private Equity and Venture Capital Valuation (IPEV) Guidelines as the central methodology for all private company valuations. The IPEV Guidelines are the prevailing framework for fair value assessment in the private equity and venture capital industry. The Directors and the Manager continue to follow industry guidelines and adhere to the IPEV Guidelines in all private company valuations. In accordance with normal market practice, investments quoted on AIM, or another recognised stock exchange, are valued at their closing bid price at the period end.

 

Environmental, Social and Governance (ESG)

 

Whilst the Manager continues to enhance its ESG framework, it should be noted that your Company's investment policy does not incorporate specific ESG aims, and portfolio companies are not required to meet any specific targets. However, as a growth investor, Maven is well positioned to help each company establish robust ESG practices at an early stage of its corporate development, ensuring that they are ingrained in the culture as the business grows. The Manager believes that strong core ESG credentials help support responsible growth and encourage positive social and environmental behaviours.

 

Your Company has multiple investments in companies with strong ESG credentials that are achieving growth in expanding markets. The Manager is committed to maintaining a responsible approach to new and existing investments, and has developed a framework for promoting ESG credentials by actively engaging with portfolio companies, taking into consideration material issues at the point of investment as well as monitoring progress annually. All potential investee companies are required to complete an ESG assessment that covers ten key areas and provides a comprehensive pre-investment evaluation of the business, with a focus on governance, board composition and culture, alongside environmental and social considerations.

 

The Manager continues to be an active signatory to the UN Principles for Responsible Investment (UNPRI) and Investing in Women Code. Alongside these external initiatives, Maven has developed diversity initiatives, including launching a Female Founder Funding programme that aims to offer mentorship and collaboration opportunities to female entrepreneurs across the UK.

 

Outlook

 

Whilst M&A activity in 2023 was stifled by market uncertainty and geopolitical concerns, there has been a strong recovery in the year to date and it is pleasing to note the completion of several high value exits. The companies in the unlisted portfolio continue to attract regular acquisition interest from a range of UK and international buyers, and completing further profitable exits to help support your Company's ongoing dividend programme remains a key objective for the second half of the year.

 

Fraser Gray

Chairman

 

18 September 2024

 

 

Summary Of Investment Changes

 

Six Months Ended 30 June 2024

 

 

Valuation

31 December 2023

Net investment/ (disinvestment)

£'000

Appreciation/ (depreciation)

£'000

Valuation

30 June 2024

 

£'000

%

£'000

%

Unlisted investments

 

 

 

 

 

 

Equities

48,291

57.5

652

4,325

53,268

59.8

Loan stock

13,382

15.9

98

(5)

13,485

15.1

 

61,673

73.4

750

4,330

66,753

74.9

 

AIM Investments1

 

 

 

 

 

 

Equities

3,894

4.6

93

(817)

3,170

3.6

 

Other investments2

 

 

 

 

 

 

OEICs

2,035

2.4

26

(25)

2,036

2.3

MMFs

4,000

4.8

1,000

-

5,000

5.5

Investment trusts

5,635

6.7

-

142

5,777

6.5

Total investments

77,237

91.9

1,869

3,630

82,736

92.8

 

Other net assets

 

6,680

 

8.1

 

(266)

 

-

 

6,414

 

7.2

Net assets

83,917

100.0

1,603

3,630

89,150

100.0

 

1   Shares traded on the Alternative Investment Market (AIM) and the Main Market of the London Stock Exchange.

2   These holdings represent the treasury management portfolio, which has been constructed from a range of carefully selected, permitted non-qualifying holdings in investment trusts, open-ended investment companies (OEICs) and money market funds (MMFs).

 

 

Investment Portfolio Summary

 

As At 30 June 2024

 

Investment

Valuation

£'000

Cost

£'000

% of

total

assets

% of

equity

held

% of equity held by other clients1

Unlisted

 

 

 

 

 

Horizon Ceremonies Limited

(trading as Horizon Cremation)

4,769

2,463

5.3

12.9

39.7

BioAscent Discovery Limited

4,713

1,532

5.2

26.1

13.9

MirrorWeb Limited

4,179

990

4.7

8.5

41.4

Bright Network (UK) Limited

3,218

1,706

3.6

9.8

29.3

Rockar 2016 Limited (trading as Rockar)

3,110

1,766

3.5

6.2

13.2

WaterBear Education Limited

2,905

987

3.3

19.9

18.9

QikServe Limited

2,038

1,674

2.3

7.6

8.2

HCS Control Systems Group Limited

1,942

1,201

2.2

10.7

25.8

Ensco 969 Limited (trading as DPP)

1,857

1,532

2.1

7.4

27.1

CB Technology Group Limited

1,813

1,097

2.0

18.6

56.4

Novatus Global Limited

1,649

562

1.8

3.5

15.2

NorthRow Limited

1,482

1,699

1.7

12.3

20.5

Vodat Communications Group (VCG) Holding Limited

1,427

1,240

1.6

8.4

23.5

Zinc Digital Business Solutions Limited

1,301

867

1.5

15.6

28.0

Summize Limited

1,275

796

1.4

4.0

30.3

Relative Insight Limited

1,201

1,201

1.3

5.7

25.6

Filtered Technologies Limited

1,184

1,100

1.3

9.7

15.8

Hublsoft Group Limited

1,138

922

1.3

7.3

16.4

ebb3 Limited

1,125

1,307

1.3

31.4

47.5

Martel Instruments Holding Limited

1,038

701

1.2

14.7

29.6

Liftango Group Limited

1,016

1,016

1.1

6.3

34.4

Whiterock Group Limited

1,014

1,014

1.1

11.2

26.7

RevLifter Limited

1,000

1,000

1.1

10.2

16.4

2degrees Limited

(trading as Manufacture 2030)

970

698

1.1

2.5

8.6

Bud Systems Limited

953

762

1.1

4.1

13.5

CYSIAM Limited

944

448

1.1

5.8

22.0

Nano Interactive Group Limited

929

625

1.0

3.7

11.2

Boomerang Commerce Inc

(trading as CommerceIQ)2

873

1,164

1.0

0.2

0.3

DiffusionData Limited

853

625

1.0

3.1

14.9

Precursive Limited

750

750

0.8

5.5

29.0

Flow UK Holdings Limited

735

1,047

0.8

12.7

22.3

Cat Tech International Limited

717

1,115

0.8

8.4

21.6

ORCHA Health Limited

709

709

0.8

2.8

5.0

Growth Capital Ventures Limited

650

639

0.7

11.5

36.0

Maven Capital (Marlow) Limited

650

650

0.7

-

100.0

Delio Limited

644

1,294

0.7

6.0

11.6

XR Games Limited

639

299

0.7

1.7

21.5

Draper & Dash Limited

(trading as RwHealth)

621

621

0.7

6.0

43.0

mypura.com Group Limited

(trading as Pura)

608

409

0.7

1.6

21.2

CODILINK UK Limited (trading as Coniq)

600

400

0.7

1.1

3.8

Metrion Biosciences Limited

597

597

0.7

4.3

13.9

Plyable Limited

597

597

0.7

6.8

19.8

Sensoteq Limited

597

597

0.7

5.6

18.0

Enpal Limited

(trading as Guru Systems)

581

581

0.7

3.2

18.4

The Algorithm People Limited

(trading as Optimize)

558

420

0.6

6.1

10.2

TC Communications Holdings Limited

551

958

0.6

12.6

22.7

iAM Compliant Limited

492

298

0.6

3.9

45.3

Horizon Technologies Consultants Limited

466

448

0.5

3.1

14.1

Biorelate Limited

419

348

0.5

2.0

23.7

Laverock Therapeutics Limited

398

398

0.4

1.9

7.5

Shortbite Limited

(trading as Fixtuur)

347

798

0.4

10.0

60.8

HiveHR Limited

346

346

0.4

4.4

40.2

Snappy Shopper Limited

309

309

0.3

0.4

1.3

AMufacture Limited

261

261

0.3

4.8

15.2

Alderley Lighthouse Labs Limited

249

249

0.3

6.7

46.9

Zing TopCo Limited (trading as Zing)

185

185

0.2

4.9

42.8

McKenzie Intelligence Services Limited

159

159

0.2

1.6

4.8

ISN Solutions Group Limited

143

467

0.2

7.8

47.2

Reed Thermoformed Packaging Limited (trading as iPac Packaging Innovations)

140

100

0.2

0.5

11.8

Rico Developments Limited

(trading as Adimo)

100

200

0.1

1.6

8.3

Other unlisted investments

19

3,699

-

 

 

Total unlisted

66,753

52,643

74.9

 

 

 

AIM quoted3

 

 

 

 

 

GENinCode PLC

454

760

0.6

6.4

15.3

MaxCyte Inc

383

207

0.5

0.1

0.1

Kanabo Group PLC4

330

2,986

0.4

3.7

6.3

Diaceutics PLC

260

161

0.3

0.3

0.3

Intelligent Ultrasound Group PLC

248

400

0.3

1.2

0.8

Oxford Metrics PLC

231

80

0.3

0.2

-

Verici Dx PLC

112

373

0.1

1.1

0.3

Eden Research PLC

111

160

0.1

0.5

1.0

KRM22 PLC

110

220

0.1

1.2

-

SkinBioTherapeutics PLC

110

208

0.1

0.7

-

One Media IP Group PLC

106

186

0.1

1.2

-

C4X Discovery Holdings PLC

96

137

0.1

0.4

0.5

Creo Medical Group PLC

89

497

0.1

0.1

-

TPXimpact Holdings PLC

66

107

0.1

0.2

-

Pulsar Group PLC

(formerly Access Intelligence PLC)

61

35

0.1

0.1

0.4

AFC Energy PLC

59

57

0.1

-

-

Cambridge Cognition Holdings PLC

59

62

0.1

0.4

1.1

Avacta Group PLC

54

16

0.1

-

-

Vianet Group PLC

43

49

-

0.1

1.3

Feedback PLC

42

121

-

0.4

1.2

Destiny Pharma PLC

27

206

-

0.3

0.3

Crossword Cybersecurity PLC

24

122

-

0.4

1.7

Spectral AI Inc

22

99

-

-

-

Angle PLC

19

82

-

0.1

-

Hardide PLC

15

122

-

0.3

0.2

ReNeuron Group PLC

13

277

-

0.7

1.4

Other quoted investments

26

1,071

-

 

 

Total AIM quoted

3,170

8,801

3.6

 

 

 

Private equity investment trusts5

 

 

 

 

 

HgCapital Trust PLC

1,012

531

1.1

-

0.1

Patria Private Equity Trust PLC

(formerly abrdn Private Equity Opportunities Trust PLC)

516

367

0.6

0.1

0.2

ICG Enterprise Trust PLC

483

381

0.5

0.1

0.1

Partners Group Private Equity Limited (formerly Princess Private Equity Holding Limited)

379

336

0.4

0.1

0.1

Apax Global Alpha Limited

370

344

0.4

-

0.1

CT Private Equity Trust PLC

362

293

0.4

0.1

0.3

NB Private Equity Partners Limited

360

371

0.4

0.1

0.2

HarbourVest Global Private Equity Limited

268

153

0.3

-

-

Pantheon International PLC

144

99

0.2

-

0.1

Total private equity investment trusts

3,894

2,875

4.3

 

 

 

Infrastructure investment trusts5

 

 

 

 

 

3i Infrastructure PLC

256

260

0.3

-

-

BBGI Global Infrastructure SA

248

280

0.3

-

0.1

International Public Partnerships Limited

238

270

0.3

-

-

Pantheon Infrastructure PLC

225

250

0.3

0.1

0.2

JLEN Environmental Assets Group Limited

187

260

0.2

-

0.1

Total infrastructure investment trusts

1,154

1,320

1.4

 

 

Fixed income investment trusts5

 

 

 

 

 

TwentyFour Income Fund Limited

175

195

0.2

0.1

-

Alcentra European Floating Rate Income Fund Limited

9

11

-

-

-

Total fixed income investment trust

184

206

0.2

 

 

 

Global equity investment trusts5

 

 

 

 

 

Alliance Trust PLC

181

149

0.2

-

-

JPMorgan Global Growth & Income PLC

157

25

0.2

-

-

Total fixed income investment trusts

338

274

0.4

 

 

 

Real estate investment trusts5

 

 

 

 

 

Impact Healthcare REIT PLC

207

235

0.2

0.1

0.1

Total real estate investment trusts

207

235

0.2

 

 

Open-ended investment companies5

 

 

 

 

 

Royal London Short Term Fixed Income Fund (Class Y Income)

1,028

1,020

1.2

0.1

0.2

Royal London Short Term Monet Market Fund (Class Y Income)

1,008

1,026

1.1

-

-

Total open-ended investment companies

2,036

2,046

2.3

 

 

Money market funds5

 

 

 

 

 

Aberdeen Standard Liquidity Fund (Lux) - Sterling Fund (Class K3)

1,000

1,000

1.1

-

-

Aviva Investors Sterling Government Liquidity Fund

1,000

1,000

1.1

-

-

BlackRock Institutional Sterling Government Liquidity Fund (Core Dis)

1,000

1,000

1.1

-

-

BlackRock Institutional Sterling Liquidity Fund (Core)

1,000

1,000

1.1

-

-

Fidelity Institutional Liquidity Sterling Fund (Class F)

1,000

1,000

1.1

0.1

0.2

Total money market funds

5,000

5,000

5.5

 

 

 

 

 

 

 

 

Total investments

82,736

73,400

92.8

 

 

 

1 Other clients of Maven Capital Partners UK LLP.

2 This holding reflects the retained minority interest following the sale of e.fundamentals (Group) Limited to CommerceIQ in July 2022.

3 Investments are quoted on AIM with the exception of Kanabo Group PLC, which is listed on the Main Market of the London Stock Exchange.

4 The holding in this investment resulted from the sale of The GP Service (UK) Limited, which completed in February 2022. The unlisted shares in Kanabo GP Limited were, in accordance with the terms of the original transaction, exchanged for shares in Kanabo Group PLC, which is listed on the Main Market of the London Stock Exchange.

5 Treasury management portfolio.

 

Shaded line indicates that the investment was completed pre November 2015.

 

 

Income Statement

 

For the Six Months Ended 30 June 2024

 

 

Six months ended to

30 June 2024 (unaudited)

Six months ended to

30 June 2023 (unaudited)

Year ended

31 December 2023 (audited)

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Gain/(loss) on investments

-

3,630

3,630

-

(1,689)

(1,689)

-

(2,989)

(2,989)

Income from investments

792

-

792

561

-

561

1,262

-

1,262

Other income

87

-

87

176

-

176

299

-

299

Investment management fees

(212)

(850)

(1,062)

(225)

(898)

(1,123)

(449)

(1,797)

(2,246)

Other expenses

(222)

-

(222)

(286)

-

(286)

(633)

-

(633)

Net return on ordinary

activities before taxation

445

2,780

3,225

226

(2,587)

(2,361)

479

(4,786)

(4,307)

Tax on ordinary activities

-

-

-

-

-

-

-

-

-

Return attributable to Equity Shareholders

445

2,780

3,225

226

(2,587)

(2,361)

479

(4,786)

(4,307)

 

Earnings per share (pence)

 

0.32

 

1.97

 

2.29

 

0.17

 

(1.92)

 

(1.75)

 

0.35

 

(3.52)

 

(3.17)

 

All gains and losses are recognised in the Income Statement.

 

The total column of this statement is the Profit & Loss Account of the Company. The revenue and capital return columns are prepared in accordance with the AIC SORP. All items in the above statement derive from continuing operations. No operations were acquired or discontinued during the period.

 

There are no potentially dilutive capital instruments in issue and, therefore, no diluted earnings per share figures are relevant. The basic and diluted earnings per share are, therefore, identical.

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Statement of Changes in Equity

 

For the six months ended 30 June 2024

 

Six months ended 30 June 2024 (unaudited)

 

 

Non-distributable reserves

Distributable reserves

 

Share capital

£'000

Share

premium

account

£'000

Capital redemption

reserve

£'000

Capital

reserve

unrealised

£'000

Capital

reserve

realised

£'000

Special

distributable

reserve

£'000

Revenue reserve

£'000

Total

£'000

 

At 31 December 2023

13,596

43,470

1,196

9,150

4,174

10,883

1,448

83,917

 

Net return

-

-

-

2,739

891

(850)

445

3,225

 

Dividends paid

-

-

-

-

-

(2,295)

(215)

(2,510)

 

Repurchase and cancellation of shares

(221)

-

221

-

-

(1,285)

-

(1,285)

 

Net proceeds of share issue

916

4,657

-

-

-

-

-

5,573

 

Net proceeds of DIS issue*

42

188

-

-

-

-

230

 

At 30 June 2024

14,333

48,315

1,417

11,889

5,065

6,453

1,678

89,150

 

 

Six months ended 30 June 2023 (unaudited)

 

Non-distributable reserves

Distributable reserves

 

 

Share capital

£'000

Share

premium

account

£'000

Capital redemption

reserve

£'000

Capital

reserve

unrealised

£'000

Capital

reserve

realised

£'000

Special

distributable

reserve

£'000

Revenue reserve

£'000

Total

£'000

At 31 December 2022

12,977

37,443

762

12,100

4,213

19,975

1,174

88,644

Net return

-

-

-

(1,893)

204

(898)

226

(2,361)

Dividends paid

-

-

-

-

-

(2,328)

(68)

(2,396)

Repurchase and cancellation of shares

(177)

-

177

-

-

(1,145)

-

(1,145)

Net proceeds of share issue

978

5,729

-

-

-

-

-

6,707

Net proceeds of DIS issue*

37

208

-

-

-

-

-

245

At 30 June 2023

13,815

43,380

939

10,207

4,417

15,604

1,332

89,694

 

Year ended 31 December 2023 (audited)

 

Non-distributable reserves

Distributable reserves

 

 

Share capital

£'000

Share

premium

account

£'000

Capital redemption

reserve

£'000

Capital

reserve

unrealised

£'000

Capital

reserve

realised

£'000

Special

distributable

reserve

£'000

Revenue reserve

£'000

Total

£'000

At 31 December 2022

12,977

37,443

762

12,100

4,213

19,975

1,174

88,644

Net return

-

-

-

(2,950)

(39)

(1,797)

479

(4,307)

Dividends paid

-

-

-

-

-

(4,580)

(205)

(4,785)

Repurchase and cancellation of shares

(434)

-

434

-

-

(2,715)

-

(2,715)

Net proceeds of share issue

978

5,615

-

-

-

-

-

6,593

Net proceeds of DIS issue*

75

412

-

-

-

-

-

487

At 31 December 2023

13,596

43,470

1,196

9,150

4,174

10,883

1,448

83,917

 

*DIS represents the Dividend Investment Scheme as detailed in the Interim Review.

 

The capital reserve unrealised is generally non-distributable other than the part of the reserve relating to gains/(losses) attributable to readily realisable quoted investments which are distributable.

 

Where all, or an element, of the proceeds of sales have not been received in cash or cash equivalent, and are not readily convertible to cash, they do not qualify as realised gains for the purposes of distributable reserves calculations and, therefore, do not form part of distributable reserves.

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Balance Sheet

 

As at 30 June 2024

 

 

30 June 2024

(unaudited)

£'000

30 June 2023

(unaudited)

£'000

31 December 2023

(audited)

£'000

Fixed assets

 

 

 

Investments at fair value through profit or loss

82,736

74,919

77,237

 

Current assets

 

 

 

Debtors

1,486

1,542

1,506

Cash

5,243

13,419

5,458

 

6,729

14,961

6,964

Creditors

 

 

 

Amounts falling due within one year

(315)

(186)

(284)

Net current assets

6,414

14,775

6,680

Net assets

89,150

89,694

83,917

 

Capital and reserves

 

 

 

Called up share capital

14,333

13,815

13,596

Share premium account

48,315

43,380

43,470

Capital redemption reserve

1,417

939

1,196

Capital reserve - unrealised

11,889

10,207

9,150

Capital reserve - realised

5,065

4,417

4,174

Special distributable reserve

6,453

15,604

10,883

Revenue reserve

1,678

1,332

1,448

Net assets attributable to Ordinary Shareholders

89,150

89,694

83,917

Net asset value per Ordinary Share (pence)

62.19

64.92

61.71

 

The Financial Statements of Maven Income and Growth VCT 4 PLC, registered number SC272568, were approved and authorised for issue by the Board of Directors and were signed on its behalf by:

 

 

Fraser Gray

Director

 

18 September 2024

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Cash Flow Statement

 

For the Six Months Ended 30 June 2024

 

 

Six months ended

30 June 2024

(unaudited)

£'000

Six months ended 30 June 2023

(unaudited)

£'000

Year ended

31 December 2023

(audited)

£'000

Net cash flows from operating activities

(612)

(662)

(1,308)

 

Cash flows from investing activities

 

 

 

Purchase of investments

(7,567)

(11,150)

(19,583)

Sale of investments

5,861

1,468

6,320

Net cash flows from investing activities

(1,706)

(9,682)

(13,263)

 

Cash flows from financing activities

 

 

 

Equity dividends paid

(2,510)

(2,396)

(4,785)

Net proceeds of DIS issue

234

245

6,707

Issue of Ordinary Shares

5,664

6,707

470

Repurchase of Ordinary Shares

(1,285)

(1,145)

(2,715)

Net cash flows from financing activities

2,103

3,411

(323)

 

 

 

 

Net decrease in cash

(215)

(6,933)

(14,894)

 

Cash as at beginning of period

 

5,458

 

20,352

 

20,352

Cash at end of period

5,243

13,419

5,458

 

The accompanying Notes are an integral part of the Financial Statements.

 

 

Notes to the Financial Statements

 

1.  Accounting Policies

 

The financial information for the six months ended 30 June 2024 and the six months ended 30 June 2023 comprises non-statutory accounts within the meaning of S435 of the Companies Act 2006. The financial information contained in this report has been prepared on the basis of the accounting policies set out in the Annual Report and Financial Statements for the year ended 31 December 2023, which have been filed at Companies House and contained an Auditor's Report that was not qualified and did not contain a statement under S498(2) or S498(3) of the Companies Act 2006.

 

2.  Reserves

 

Share premium account

 

The share premium account represents the premium above nominal value received by the Company on issuing shares net of issue costs, including £67,880 current period trail commission (cumulative £181,574). This reserve is non-distributable.

 

Capital redemption reserve

 

The nominal value of shares repurchased and cancelled is represented in the capital redemption reserve. This reserve is non-distributable.

 

Capital reserve - unrealised

 

Increases and decreases in the fair value of investments are recognised in the Income Statement and are then transferred to the capital reserve unrealised account. This reserve is generally non-distributable, other than the part of the reserve relating to gains/ (losses) attributable to readily realisable quoted investments that are distributable.

 

Capital reserve - realised

 

Gains or losses on investments realised in the year that have been recognised in the Income Statement are transferred to the capital reserve realised account on disposal. Furthermore, any prior unrealised gains or losses on such investments are transferred from the capital reserve unrealised account to the capital reserve realised account on

disposal. This reserve is distributable.

 

Special distributable reserve

 

The total cost to the Company of the repurchase and cancellation of shares is represented in the special distributable reserve account. The special distributable reserve also represents capital dividends, capital investment management fees and the tax effect of capital items. This reserve is distributable.

 

Revenue reserve

 

The revenue reserve represents accumulated profits retained by the Company that have not been distributed to Shareholders. This reserve is distributable.

 

3.  Return per Ordinary Share

 

 

Six months ended 30 June 2024

The returns per share have been based on the following figures:

 

Weighted average number of Ordinary Shares

 

Revenue return

Capital return

 

 

141,047,313

 

£445,000

£2,780,000

Total return

£3,225,000

 

Directors' Responsibility Statement

 

Each Director believes that, to the best of their knowledge:

 

·     the Financial Statements for the six months ended 30 June 2024 have been prepared in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland;

 

·     the Interim Management Report includes a fair review of the information required by DTR 4.2.7R in relation to the indication of important events during the first six months, and of the principal and emerging risks and uncertainties facing the Company during the second six months, of the year ending 31 December 2024; and

 

·     the Interim Management Report includes adequate disclosure of the information required by DTR 4.2.8R in relation to material related party transactions and any changes therein.

 

Other information

 

The NAV per Ordinary Share has been calculated using the number of Ordinary Shares in issue at 30 June 2024, which was 143,341,152. A Summary of Investment Changes for the six months under review and an Investment Portfolio Summary as at 30 June 2024 are included above. A full copy of the Interim Report and Financial Statements will be printed and issued to Shareholders in due course. Copies of this announcement will be available to the public at the registered office of the Company at Kintyre House, 205 West George Street, Glasgow G2 2LW; at the office of the Manager, Maven Capital Partners UK LLP, Saddlers House, 44 Gutter Lane, London, EC2V 6BR; and, in due course, on the Company's webpage at mavencp.com/migvct4.

 

Neither the content of the Company's webpages nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

 

On behalf of the Board

Maven Capital Partners UK LLP

Secretary

 

18 September 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR EAENPFEPLEFA

1 Year Maven Income & Growth Vc... Chart

1 Year Maven Income & Growth Vc... Chart

1 Month Maven Income & Growth Vc... Chart

1 Month Maven Income & Growth Vc... Chart

Your Recent History

Delayed Upgrade Clock